• Symbiox Investment & Trading Co. Ltd. files a regulatory compliance statement with BSE, CSE, and MSE.
• The company confirms it did not raise any funds through public, rights, or preferential issues in Q4 FY26.
• Consequently, a statement of deviation in fund utilization under SEBI LODR Reg. 32 is not applicable.